So if this is true ,
Why lenzilumab patients accepted for a study are really moderate to slightly severe , Why not really sick if drug THAT good ??
Why to exclude all with secondary viral , bacterial or fungi infections , leronlimab taking all these patients..
And WHY not one after lenzilimab patients is off ECMO and many by now after leronlimab..
And why with ALL your connections , you dont have EIND or OLE..?
( I believe you dont , am I wrong )
WHY ???
All imo.